null

Low Endotoxin Purified Anti-Human CD274/PD-L1 Antibody [29E.2A3] (AGEL1645)

SKU:
AGEL1645
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human
Applications:
FC
€229 - €1,219
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Low Endotoxin Purified Anti-Human CD274/PD-L1 Antibody [29E.2A3]

The Monoclonal Antibody (AGEL1645) specific for Human CD274/PD-L1 is a vital tool for researchers investigating the PD-L1 pathway and its role in cancer immunotherapy. This antibody, known as 29E.2A3, is purified and exhibits high specificity for the CD274 protein, an immune checkpoint molecule that serves as a key regulator of the immune response.PD-L1, also called Programmed Death-Ligand 1, is a crucial immune checkpoint protein that plays a significant role in suppressing the immune system's response to cancer cells. By targeting PD-L1, researchers can gain valuable insights into the mechanisms by which tumors evade immune detection and explore novel therapeutic strategies for enhancing anti-tumor immune responses.

The Monoclonal Antibody 29E.2A3 (AGEL1645) is validated for various applications, including immunohistochemistry and flow cytometry, enabling precise detection and analysis of CD274/PD-L1 expression in different cell types and tissues. Its specificity and reliability make it an indispensable tool for studies focused on cancer biology, immunotherapy, and immune evasion mechanisms, providing critical information for the development of innovative treatments targeting the PD-L1 pathway.